Loading...
Cannabinoid receptor type 1 antagonist inhibits progression of obesity‐associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances
SCOPE: This study investigated whether AM251, a cannabinoid receptor type 1 (CB1) antagonist, ameliorates hepatic levels of metabolic abnormalities and inflammatory responses in a murine nonalcoholic steatohepatitis (NASH) model via reversal of disturbances in the immune system. METHODS AND RESULTS:...
Na minha lista:
| Udgivet i: | Immun Inflamm Dis |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7654409/ https://ncbi.nlm.nih.gov/pubmed/32798334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.338 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|